Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel

BACKGROUND: Clopidogrel is a prodrug requiring metabolism by cytochrome P450 3A (CYP3A) isoenzymes, including CYP3A5, in order to be active. It is controversial whether clopidogrel interacts with CYP3A inhibitors. We investigated the influence of CYP3A5 polymorphism on the drug interaction of clopid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Suh, Jung-Won, Koo, Bon-Kwon, Zhang, Shu-Ying, Park, Kyung-Woo, Cho, Joo-Youn, Jang, In-Jin, Lee, Dong-Soon, Sohn, Dae-Won, Lee, Myoung-Mook, Kim, Hyo-Soo
Formato: Artigo
Idioma:Inglês
Publicado em: Canadian Medical Association 2006
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1471813/
https://ncbi.nlm.nih.gov/pubmed/16754899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.060664
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados